[1] |
FURIE B, FURIE BC.Mechanisms of thrombus formation[J]. N Engl J Med, 2008, 359(9): 938-949.
|
[2] |
FROSSARD M, FUCHS I, LEITNER JM, et al.Platelet function predicts myocardial damage in patients with acute myocardial infarction[J].Circulation, 2004, 110(11): 1392-1397.
|
[3] |
MICHELSON AD.Platelet function testing in cardiov-ascular diseases[J]. Circulation, 2004, 110(19): e489-e493.
|
[4] |
李晶华, 李智, 王吉影, 等. 2型糖尿病患者血小板-白细胞聚集体和血小板活化指标的研究[J].中华检验医学杂志, 2012, 35(10): 940-944.
|
[5] |
ELALAMY I, CHAKROUN T, GEROTZIAFAS GT, et al.Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients[J].Thromb Res, 2008, 121(6): 843-848.
|
[6] |
RIEGER S, ENDLER G, MANNHALTER C, et al.To: Tschoepe D, Menart B, Ferber P, et al. (2003) Genetic variation of the platelet surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with type 2 diabetes mellitus[J].Diabetologia, 2004, 47(4): 761-762.
|
[7] |
LPEZ E, BERNA-ERRO A, HERNNDEZ-CRUZ JM, et al. Immunophilins are involved in the altered platelet aggregation observed in patients with type 2 diabetes mellitus[J].Curr Med Chem, 2013, 20(14): 1912-1921.
|
[8] |
叶山东,李素梅,莫蔚林,等. 糖尿病合并白蛋白尿患者血小板聚集功能和膜蛋白表达的变化[J].中国糖尿病杂志, 2001,9(4): 207-209.
|
[9] |
邓艳,张朝典. 糖尿病患者血液流变学、血小板聚集功能及血脂检测的意义[J].内科急危重症杂志, 2007,13(6): 306-307.
|
[10] |
KONSTANTOPOULOS K, NEELAMEGHAM S, BURNS AR, et al.Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin[J].Circulation, 1998, 98(9): 873-882.
|
[11] |
饶绘, 赵惠, 李彬, 等. PCI术前测定血小板表面P-选择素的意义[J].检验医学, 2012, 27(1): 12-14.
|
[12] |
LIEVENS D, ZERNECKE A, SEIJKENS T, et al.Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis[J].Blood, 2010, 116(20): 4317-4327.
|
[13] |
FRANKS ZG, CAMPBELL RA, WEYRICH AS, et al.Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke[J].Ann N Y Acad Sci, 2010, 1207: 11-17.
|
[14] |
GLASS CK, WITZTUM JL.Atherosclerosis, the road ahead[J].Cell, 2001, 104(4): 503-516.
|
[15] |
KOYAMA H, MAENO T, FUKUMOTo S, et al.Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans[J]. Circulation, 2003, 108(5): 524-529.
|
[16] |
SHOJI T, KOYAMA H, FUKUMOTO S, et al.Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis[J]. Atherosclerosis, 2006, 188(1): 190-195.
|
[17] |
HTUN P, FATEH-MOGHADAM S, TOMANDL B, et al.Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia[J]. Stroke, 2006, 37(9): 2283-2287.
|
[18] |
Habazettl H, Hanusch P,Kupatt C. Effects of endothelium/leukocytes/platelet interaction on myocardial ischemia--reperfusion injury[J].Z Kardiol, 2000, 89(Suppl 9): IX/92-IX/95.
|
[19] |
WANG Y, ZHANG H.Platelet-induced inhibition of tumor cell growth[J].Thromb Res, 2008, 123(2): 324-330.
|
[20] |
CHO MS, BOTTSFORD-MILLER J, VASQUEZ HG.Platelets increase the proliferation of ovarian cancer cells[J].Blood, 2012, 120(24): 4869-4872.
|
[21] |
NIESWANDT B, HAFNER M, ECHTENACHER B, et al.Lysis of tumor cells by natural killer cells in mice is impeded by platelets[J].Cancer Res, 1999, 59(6): 1295-1300.
|
[22] |
SCHUMACHER D, STRILIC B, SIVARAJ KK.Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor[J].Cancer Cell, 2013, 24(1): 130-137.
|
[23] |
GAY LJ, FELDING-HABERMANN B.Contribution of platelets to tumour metastasis[J].Nat Rev Cancer, 2011, 11(2): 123-134.
|
[24] |
WANG Y, SUN Y, LI D, et al.Platelet P2Y12 is involved in murine pulmonary metastasis[J].PLoS One, 2013, 8(11): e80780.
|
[25] |
包文鑫, 李佳增,陈炳献. 比浊法测定血小板聚集性[J].中华血液学杂志, 1980, 1(4): 225-228.
|
[26] |
SIERKO E, WOJTUKIEWICZ MZ.Platelets and angiogenesis in malignancy[J].Semin Thromb Hemost, 2004, 30(1): 95-108.
|
[27] |
BATTINELLI EM, MARKENS BA, ITALIANO JE JR.Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis[J]. Blood, 2011, 118(5): 1359-1369.
|
[28] |
KHORANA AA, KUDERER NM, CULAKOVA E, et al.Development and validation of a predictive model for chemotherapy-associated thrombosis[J].Blood, 2008, 111(10): 4902-4907.
|
[29] |
AY C, SIMANEK R, VORMITTAG R.High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)[J].Blood, 2008, 112(7): 2703-2708.
|
[30] |
黄智勇, 曾国琼, 谭旭东, 等. 血小板激活与活动期发生溃疡性结肠炎的关系[J].中国基层医药, 2006, 13(3): 386-387.
|
[31] |
CARTY E, MACEY M, MCCARTNEY SA, et al.Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist:anti-inflammatory profile in inflammatory bowel disease[J].Aliment Pharmacol Ther, 2000, 14(6): 807-817.
|
[32] |
OSTROWSKI SR, BERG RM, WINDELØV NA, et al. Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers[J].PLoS One, 2013, 8(3): e59368.
|
[33] |
冷承慧. 92例脓毒症患者血小板计数动态变化的临床分析[J].河南科技大学学报(医学版), 2012, 30(2): 130-131.
|
[34] |
乔蕊,张捷. 抗血小板药物治疗监测的进展[J].检验医学, 2013, 28(5): 442-447.
|
[35] |
董静懿,李培成. 冠心病患者血小板CD62p及Gp Ⅱb/Ⅲa的变化[J].检验医学, 2005, 20(3): 189-191.
|
[36] |
凌利芬, 朱新建, 王海, 等. 采血后不同时间内检测血小板聚集功能分析[J].国际检验医学杂志, 2010, 31(10): 1099-1100.
|